Fundraise / allotmentNotableFiled on BSE ·

Neogen Chemicals Ltd announces Q1 FY2026-27 results and board decisions on July 24, 2026

Neogen Chemicals · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹600 CrFundraise / allotment

Key highlights

  • Approved unaudited standalone and consolidated Q1 FY2026-27 financial results with no deviations in preferential issue fund utilization.
  • Received in-principle approval to raise funds up to ₹600 crore via equity or other securities including QIP, subject to approvals.
  • Crisil downgraded rating on July 17, 2026; coupon rate on ₹200 crore NCDs increased from 10.50% to 11.00% p.a. from same date.

Why it's rated notable: amount is ₹500 crore or more

Original filing

Announcement under Regulation 30 (LODR)-Raising of Funds

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.